对心肌梗塞中心室电活动的交感性缩的影响
Xiaowei Qiu1, Zhengyu Feng1, Caixia Lin1
1Department of Cardiology, Shanghai Ruijin Hospital Luwan Branch, Shanghai Jiao Tong University School of Medicine.
The Tohoku journal of experimental medicine
|June 5, 2024
概括
交感性脏缩有效地减少心肌梗塞 (MI) 和除后心室动的早期复发. 这种治疗改善了心电图 (ECG) 的稳定性,并通过降低交感神经活动来减少心肌损伤.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 电子生理学 电子生理学
背景情况:
- 心肌梗塞 (MI) 经常导致心室动 (VF),这是一个严重的心血管疾病.
- 在心脏病发作后的患者中除后的VF的早期复发是一个重要的临床挑战.
- 了解早期VF复发的电生理学指标和治疗干预措施至关重要.
研究的目的:
- 调查心脏病发作患者中早期VF复发后除的电生理学指标之间的关系.
- 在此背景下,评估同情性脏缩的治疗益处和潜在机制.
- 探索对心肌损伤和对感性神经活动的交感性损伤的影响.
主要方法:
- 使用动物模型研究后心脏病发作后的VF和除.
- 向小鼠的一个子集进行了交感性损伤,并将结果与对照组进行了比较.
- 进行心电图 (ECG) 监测,心肌组织学和神经递质分析.
主要成果:
- 早期VF复发后除与增加的ST段升高和T波变化有关.
- 交感性脏缩显著减少了早期VF复发,导致更稳定的心电图读数.
- 组织学分析显示,干预组的心肌细胞损伤和纤维化减少.
- 神经递质测定表明,在脏缩后,同情神经活动显著减少.
结论:
- 交感性脏皮表现出显著的治疗效益,减少心脏病发作和除后的早期VF复发.
- 这种干预改善了心电图参数,并减轻了心肌损伤,可能是通过减少了交感神经活动.
- 交感性脏缩是一种有前途的治疗策略,用于管理心脏病后心室节律失常.
更多相关视频
08:01Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System
Published on: June 11, 2020
8.1K
11:08Novel Approach for Simultaneous Recording of Renal Sympathetic Nerve Activity and Blood Pressure with Intravenous Infusion in Conscious, Unrestrained Mice.
Published on: February 14, 2018
10.1K
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
Heart Failure Drugs: Diuretics
363
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
363
Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
